Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
about
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@ast
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@en
type
label
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@ast
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@en
prefLabel
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@ast
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@en
P2860
P50
P1476
Pretreatment Lymphopenia, Poor ...... with Bortezomib-based Regimens
@en
P2093
Soo-Jeong Kim
Yundeok Kim
P2860
P304
P356
10.3346/JKMS.2016.31.4.510
P50
P577
2016-02-22T00:00:00Z